Insight

Dhruba Deb: The 8 SCLC projects Lung Cancer Research Foundation recently funded

Photo taken from Dhruba Deb/LinkedIn

May 19, 2024, 10:55

Dhruba Deb: The 8 SCLC projects Lung Cancer Research Foundation recently funded

Dhruba Deb, at Lung Cancer Research Foundation, shared on LinkedIn:

“As treatment options for SCLC have always been limited, accelerated FDA approval of Tarlatamab-dlle for extensive stage SCLC is a celebration for patients and advocates and an ode to the past and present research.

At Lung Cancer Research Foundation, I’m remembering the 8 SCLC projects we recently funded!

Uncovering novel vulnerabilities to treat SCLC therapy resistance- Ann Pendergast.
Using Social Determinants of Health to Predict Adherence of Lung Cancer Screening in Minority High-Risk Smokers- Loretta Erhunmwunsee.
Pulmonary high-grade neuroendocrine carcinomas as indications for antibody-drug conjugates targeting TROP2 and HER2– Carl Gay.
Harnessing DLL3 as a CAR T target in small cell lung cancer- Bingnan Zhang.
A Human Pluripotent Stem Cell-Based Approach to Metastasis of Small Cell Lung Cancer- Huanhuan Chen.
Deep whole genome sequencing of circulating tumor DNA for studying evolution and therapy resistance in small cell lung cancer- Benjamin B. Morris.
Targeting MAST1-BCL2 signaling in small cell lung cancer- Lingtao Jin.
Targeting tumor-immune microenvironment to improve durvalumab efficacy in small celllung cancer- Lingtao Jin.”

Dhruba Deb

Source: Dhruba Deb/LinkedIn

Ann Pendergast Benjamin B. Morris Bingnan Zhang cancer Carl Gay Dhruba Deb Durvalumab FDA HER2 Huanhuan Chen Lingtao Jin Loretta Erhunmwunsee Lung Cancer Research Foundation lung cancer screening OncoDaily Oncology SCLC small cell lung cancer Tarlatamab TROP2

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage